In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Generics
Privately-held US generics drugmaker Amneal has announced Rochelle Fuhrmann has joined the company as chief financial officer. 14 January 2014
Pharmaceutical
China-based ShangPharma has named Mitchell Reff as the company’s chief biologics officer. 13 January 2014
Pharmaceutical
Swiss drug major Novartis said on Sunday (January 12), that Herve Hoppenot, president of Novartis Oncology, will leave the company with immediate effect having decided to “pursue a career opportunity outside of the organization.” 13 January 2014
Pharmaceutical
French drugmaker Ipsen has appointed Jonathan Barnsley as executive vice president in charge of technical operations. 10 January 2014
Pharmaceutical
UK-based drug company Heptares Therapeutics has appointed Tim Tasker as chief medical officer and vice president of development. 10 January 2014
Pharmaceutical
German privately-owned pharma company Priaxon AG has appointed Constance Hoefer as chief development officer (CDO) to oversee non-clinical and early clinical development. 9 January 2014
Generics
Somewhat sooner than expected, Isael’s Teva Pharmaceutical Industries, the world’s largest generics drugmaker, has confirmed recent reports, saying that Erez Vigodman has been appointed president and chief executive, effective February 11. 9 January 2014
Biotechnology
Merck Serono, the biotech unit of Germany’s Merck KGaA (MRK: DE), has named Steven Hildemann as global chief medical officer and head of global medical and safety for the Merck Serono division. 9 January 2014
Biotechnology
US biotech company Promedior has announced that industry veteran William Hodder has joined the company as Vice President of Business Development. 8 January 2014
Pharmaceutical
US biopharmaceutical company Blend Therapeutics has appointed pharmaceutical industry veteran Richard Wooster as chief scientific officer. 7 January 2014
Generics
Speculation is mounting that Israel’s Teva Pharmaceutical Industries is about to appoint a new chief executive, after ousting 18-month incumbent of the post, Jeremy Levin, last October. 7 January 2014
Pharmaceutical
Canadian drugmaker AEterna Zentaris (TSX: AEZ) has appointed Richard Sachse as senior vice president, chief scientific officer. 4 January 2014
Generics
US drugmaker Mylan says that Rakesh Bamzai has joined the company and has been appointed president, India commercial and emerging markets. 4 January 2014
Biotechnology
US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel collaboration to develop DNA-based therapeutics for Friedreich's ataxia, a rare genetic neurodegenerative disease. 1 January 2014
Biotechnology
The supervisory board of German drugs and chemicals major Bayer (BAYN: DE) has appointed Kemal Malik to the Board of Management with the responsibility for innovation and taking over the North America region. 20 December 2013
Pharmaceutical
French pharmaceutical company Ipsen has announced the appointment of Dominique Brard as Executive Vice President in charge of Human Resources of the Ipsen group in place of Etienne de Blois. 19 December 2013
Pharmaceutical
Sydney-based companion diagnostic and personalized medicine company Clarity has appointed Alan Taylor as its new executive chairman to the board. 19 December 2013
Pharmaceutical
When it comes to being different, privately-owned Ferring Pharma is proud of its culture of enterprise driven by science, not profit. 18 December 2013
Pharmaceutical
Changes in Pfizer’s (NYSE: PFE) executive leadership have been announced this week. 18 December 2013
Biotechnology
German biotechnology company Lophius Biosciences GmbH has announced that Dr Robert Phelps has joined the company as director of business operations. 16 December 2013
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze